As global trade dynamics shift, manufacturers—especially in the medical devices sector—face unprecedented cost pressures, supply chain disruptions, and regulatory hurdles due to evolving US tariffs. With nearly 75% of US-sold medical devices sourced partially or entirely overseas, the financial and operational risks are significant, impacting innovation, patient access, and long-term competitiveness.
This exclusive whitepaper from Muralidharan K offers a strategic roadmap to mitigate tariff-related risks through:
- Supply Chain Diversification & Nearshoring: Alternate sourcing and relocation strategies to reduce cost burdens.
- Predictive Supply Chain Intelligence: AI- and IoT-driven visibility for proactive risk management.
- Regionalization & Plant Transfer Engineering: Regulatory-compliant, seamless manufacturing transitions.
- Workforce Enablement & Advocacy: Upskilling, policy engagement, and partnerships for resilience.
With proven expertise across engineering, regulatory compliance, and digital transformation, LTTS helps manufacturers safeguard margins, ensure continuity, and build future-ready operations.
Download the whitepaper to explore practical strategies, industry insights, and tailored recommendations that can help your organization turn tariff challenges into opportunities for growth.